Actively Recruiting

Age: 0 - 17Years
All Genders
NCT05937828

OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia

Led by University Hospital, Bordeaux · Updated on 2023-07-10

3500

Participants Needed

9

Research Sites

1008 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

From 2004, OBS'CEREVANCE is a national real-world prospective clinical cohort of patients with auto-immune cytopenia of pediatric-onset : Immune thrombocytopenia (ITP), Autoimmune Hemolytic anemia (AIHA), or Evans syndrome (all bi or tri cytopenias). Thanks to the collaboration of the 30 French pediatric hematologic centers, this cohort supports all of the Rare Disease Centre CEREVANCE (Centre de Référence National des Cytopénies Auto-Immunes de l'Enfant) missions for care, education and research. Specifically, this original unbiased database allows to describe the long-term health of adult patients, to identify the heterogenous genetic underlying pathophysiologic contexts, and to study the benefit-risk balance of treatments, including the growing development of targeted therapies.

CONDITIONS

Official Title

OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia

Who Can Participate

Age: 0 - 17Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of ITP, AIHA, Evans Syndrome
  • Onset before the age of 18
Not Eligible

You will not qualify if you...

  • Opposition of legal representative or to data collection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

CHU Amiens Picardie Service d' Onco-Immuno-Hématologie Pédiatrique

Amiens, France

Actively Recruiting

2

CHU d'Angers Unité d'Hémato-Oncologie Pédiatrique

Angers, France

Actively Recruiting

3

BESANCON CHU de Besançon Hôpital Jean MINJOZ Unité d'Hémato-Oncologie Pédiatrique, Pédiatrie 1

Besançon, France

Actively Recruiting

4

CHU de Bordeaux - Unité d'Hématologie et d'Oncologie pédiatrique

Bordeaux, France

Actively Recruiting

5

CHU BREST Hôpital Morvan Unité d'Onco-Hématologie

Brest, France

Actively Recruiting

6

CHU de Caen Unité d'Onco-Hématologie

Caen, France

Actively Recruiting

7

CHU de Clermont Ferrand

Clermont-Ferrand, France

Actively Recruiting

8

APHP Hôpital Bicêtre Service de Pédiatrie générale

Paris, France

Actively Recruiting

9

CH de Cornouaille Service de Pédiatrie

Quimper, France

Actively Recruiting

Loading map...

Research Team

N

Nathalie ALADJIDI, MD

CONTACT

A

Aurore Capelli

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here